Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael T. Constantino Insider Profile
4 Followers
Michael T. Constantino, Director at 9 Meters Biopharma, holds 9.25K shares in Humacyte (Ticker: HUMA), holds 10.91K shares in 9 Meters Biopharma (Ticker: NMTRQ). Most recently, Michael T. Constantino Bought ― shares of Humacyte on May 19, 2023 for an estimated value of 19.86K.
Michael T. Constantino 9 Meters Biopharma (NMTRQ)Director
9 Meters Biopharma (NMTRQ)
Director
Ranked #82,463 out of 99,024 Corporate Insiders
Profitable Transactions
2 out of 6 Profitable Transactions
Average Return
-22.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael T. Constantino holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 21, 2020 - Aug 21, 2021
Return:+66.80%
The most profitable trade made by Michael T. Constantino
Michael T. Constantino's Trading History
9 Meters Biopharma
Mar 31, 2023
Director
Uninformative Buy
―
$218.22
Humacyte
May 19, 2023
Director
Informative Buy
19.86K
$58.55K
List of latest transactions for each holding click on a transaction to see Michael T. Constantino's performance on stock
You May Also Like
Michael T. Constantino insider profile FAQ
What is the percentage of profitable transactions made by Michael T. Constantino?
The percentage of profitable transactions made by Michael T. Constantino is 33%.
What is the average return per transaction made by Michael T. Constantino?
The average return per transaction made by Michael T. Constantino is -22.40%.
What stocks does Michael T. Constantino hold?
Michael T. Constantino holds: NMTRQ, HUMA stocks.
What was Michael T. Constantino’s latest transaction?
Michael T. Constantino latest transaction was an Informative Buy of $19.86K.
What was Michael T. Constantino's most profitable transaction?
Michael T. Constantino’s most profitable transaction was an Informative Buy of NMTRQ stock on August 21, 2020. The return on the trade was 66.80%.
What is Michael T. Constantino's role in 9 Meters Biopharma?
Michael T. Constantino's role in 9 Meters Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.